Valuation: Smith & Nephew Plc

Capitalization 14.76B 12.73B 11.49B 11.03B 20.1B 1,357B 21.04B 136B 54.42B 651B 55.41B 54.23B 2,327B P/E ratio 2025
23.3x
P/E ratio 2026 * 19.9x
Enterprise value 17.44B 15.04B 13.58B 13.03B 23.75B 1,603B 24.86B 160B 64.3B 769B 65.47B 64.07B 2,749B EV / Sales 2025
2.3x
EV / Sales 2026 * 2.64x
Free-Float
99.43%
Yield 2025 *
2.4%
Yield 2026 * 2.29%
1 day-1.19%
1 week-6.34%
Current month-6.34%
1 month+1.38%
3 months+1.54%
6 months-9.06%
Current year+3.71%
1 week 1,276.5
Extreme 1276.5
1,396.5
1 month 1,257
Extreme 1257
1,396.5
Current year 1,170.5
Extreme 1170.5
1,396.5
1 year 937.8
Extreme 937.8
1,441.5
3 years 887
Extreme 887
1,441.5
5 years 887
Extreme 887
1,601.5
10 years 887
Extreme 887
2,023
Manager TitleAgeSince
Chief Executive Officer - 31/03/2022
Director of Finance/CFO 58 31/03/2024
Chief Tech/Sci/R&D Officer 59 31/07/2016
Director TitleAgeSince
Director/Board Member 68 17/09/2017
Director/Board Member 67 30/09/2017
Director/Board Member 62 31/10/2020
Change 5d. change 1-year change 3-years change Capi.($)
-1.65%-6.34%+11.16%+6.29% 14.76B
-1.74%-5.97%-4.70%+36.25% 142B
-3.11%-9.72%+5.33%+123.20% 6.51B
+1.28%-1.75%-16.35%-66.18% 6.07B
+0.15%-6.35%+35.52%+28.87% 2.67B
+1.83%-1.43%-14.44%-22.86% 2.01B
-1.08%+5.67%+16.68%-16.49% 1.9B
-0.38%-4.46%-64.80%-76.84% 1.79B
-4.66%-8.91%+15.91%+16.71% 1.4B
Average -1.00%-4.66%-1.74%+3.22% 19.88B
Weighted average by Cap. -1.57%-4.03%-3.14%+30.84%

Financials

2025 2026 *
Net sales 6.14B 5.29B 4.78B 4.58B 8.36B 564B 8.75B 56.46B 22.62B 270B 23.03B 22.54B 967B 6.53B 5.63B 5.08B 4.87B 8.89B 600B 9.3B 60.04B 24.05B 288B 24.49B 23.97B 1,028B
Net income 664M 572M 517M 496M 904M 61.02B 946M 6.11B 2.45B 29.26B 2.49B 2.44B 105B 745M 642M 580M 556M 1.01B 68.47B 1.06B 6.86B 2.75B 32.84B 2.8B 2.74B 117B
Net Debt 2.68B 2.31B 2.09B 2B 3.65B 246B 3.82B 24.66B 9.88B 118B 10.06B 9.84B 422B 2.48B 2.14B 1.93B 1.85B 3.38B 228B 3.54B 22.83B 9.15B 109B 9.31B 9.11B 391B
Logo Smith & Nephew Plc
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.7%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.4%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.8% of net sales.
Employees
17,000
Date Price Change Volume
06/03/26 1,284.50 p -1.65% 2,177,995
05/03/26 1,306.00 p -2.25% 2,700,404
04/03/26 1,336.00 p -1.76% 3,753,590
03/03/26 1,360.00 p +3.58% 3,676,276
02/03/26 1,313.00 p -4.27% 5,328,677
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
17.37USD
Average target price
19.06USD
Spread / Average Target
+9.70%

Quarterly revenue - Rate of surprise